Your browser doesn't support javascript.
loading
First-line pembrolizumab vs chemotherapy in metastatic non-small-cell lung cancer: KEYNOTE-024 Japan subset.
Satouchi, Miyako; Nosaki, Kaname; Takahashi, Toshiaki; Nakagawa, Kazuhiko; Aoe, Keisuke; Kurata, Takayasu; Sekine, Akimasa; Horiike, Atsushi; Fukuhara, Tatsuro; Sugawara, Shunichi; Umemura, Shigeki; Saka, Hideo; Okamoto, Isamu; Yamamoto, Nobuyuki; Sakai, Hiroshi; Kishi, Kazuma; Katakami, Nobuyuki; Horinouchi, Hidehito; Hida, Toyoaki; Okamoto, Hiroaki; Atagi, Shinji; Ohira, Tatsuo; Han, Shi Rong; Noguchi, Kazuo; Ebiana, Victoria; Hotta, Katsuyuki.
Afiliação
  • Satouchi M; Department of Thoracic Oncology, Hyogo Cancer Center, Akashi, Japan.
  • Nosaki K; Department of Thoracic Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
  • Takahashi T; Division of Thoracic Oncology, Shizuoka Cancer Center, Shuntougun, Japan.
  • Nakagawa K; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan.
  • Aoe K; Department of Medical Oncology, National Hospital Organization Yamaguchi Ube Medical Center, Ube, Japan.
  • Kurata T; Department of Thoracic Oncology, Kansai Medical University, Osaka, Japan.
  • Sekine A; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Kanagawa, Japan.
  • Horiike A; Department of Thoracic Medical Oncology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Fukuhara T; Department of Respiratory Medicine, Miyagi Cancer Center, Natori, Japan.
  • Sugawara S; Department of Pulmonary Medicine, Sendai Kousei Hospital, Miyagi, Japan.
  • Umemura S; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Saka H; Department of Respiratory Medicine and Medical Oncology, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Okamoto I; Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Yamamoto N; Internal Medicine III, Wakayama Medical University, Wakayama, Japan.
  • Sakai H; Department of Thoracic Oncology, Saitama Cancer Center, Saitama, Japan.
  • Kishi K; Department of Respiratory Medicine, Respiratory Center, Totanomon Hospital, Tokyo, Japan.
  • Katakami N; Division of Integrated Oncology, Institute of Biomedical Research and Innovation Hospital, Kobe, Japan.
  • Horinouchi H; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Hida T; Department of Thoracic Oncology, Aichi Cancer Center, Aichi, Japan.
  • Okamoto H; Department of Respiratory Medicine and Medical Oncology, Yokohama Municipal Citizen's Hospital, Yokohama, Japan.
  • Atagi S; Department of Thoracic Oncology, National Hospital Organization Kinki-Chuo Chest Medical Center, Sakai, Japan.
  • Ohira T; Department of Surgery, Tokyo Medical University, Tokyo, Japan.
  • Han SR; MSD K.K., Tokyo, Japan.
  • Noguchi K; MSD K.K., Tokyo, Japan.
  • Ebiana V; Merck & Co., Inc., Kenilworth, NJ, USA.
  • Hotta K; Center for Innovative Clinical Medicine, Okayama University Hospital, Okayama, Japan.
Cancer Sci ; 111(12): 4480-4489, 2020 Dec.
Article em En | MEDLINE | ID: mdl-32926507
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células não Pequenas / Anticorpos Monoclonais Humanizados / Antígeno B7-H1 / Antineoplásicos Imunológicos / Neoplasias Pulmonares Tipo de estudo: Clinical_trials Limite: Aged80 País/Região como assunto: Asia Idioma: En Revista: Cancer Sci Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células não Pequenas / Anticorpos Monoclonais Humanizados / Antígeno B7-H1 / Antineoplásicos Imunológicos / Neoplasias Pulmonares Tipo de estudo: Clinical_trials Limite: Aged80 País/Região como assunto: Asia Idioma: En Revista: Cancer Sci Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão